Table 4.

The characteristics of the recent group of patients (2013–2020) who developed late-onset cholecystitis.

Parameters	Late-Onset Cholecystitis	No Late-Onset Cholecystitis	p-Value
No. of patients	1 (7.1)	13 (92.9)
Gender (M/F)	1 (100)/0 (0)	6 (46.2)/7 (53.8)	0.299
Age (year, mean ± SD)	80	80 ± 10.4	0.173
Presence of GB stone	0 (0)	1 (7.7)	0.773
Presence of diabetes	1 (100)	2 (15.4)	0.047
AST	37	124.7 ± 183.68	0.374
ALT	27	71.2 ± 88.37	0.233
TB	0.37	4.8 ± 4.0	0.301
DB	0.21	4.4 ± 3.57	0.301
Pre-ERCP cholangitis	0 (0)	8 (61.5)	0.231
GB filling with contrast medium	0 (0)	3 (23.1)	0.588
Invasion of the cystic duct orifice	1 (100)	7 (53.8)	0.369
GB filling with contrast medium and invasion of the cystic duct	0 (0)	2 (15.4)	0.672
Length of the common part of the Y-stent (cm)	4	4 ± 1.2	0.267
Stent patent days	321	96 ± 128.0	0.082
Stent obstruction	1 (100)	2 (15.4)	0.047
Repeated procedure due to stent obstruction	1 (100)	2 (15.4)	0.047
Survival days	434	179 ± 154.0	0.374

Data are presented as mean ± SD. ERCP, endoscopic retrograde cholangiopancreatography; GB, gallbladder; AST, aspartate transaminase; ALT, alanine transaminase; TB, total bilirubin; DB, direct bilirubin.